Is BridgeBio Pharma, Inc. (BBIO) a Buy, Sell, or Hold?
NASDAQ : BBIO
BridgeBio Pharma, Inc. — Competitors
$82.075 USD
$2.12 (2.65%)
- Volume
- 905.62K
- Average Volume
- 3.58M
- Market Capitalization
- $16.08B
- P/E Ratio
- -21.89
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $93.42
- Year Low
- $42.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.44
BBIO vs. The Competition
| Properties | BBIO | ASND | BMRN | EXEL |
|---|---|---|---|---|
| Market Cap | $16.08B | $15.25B | $11.72B | $14.11B |
| Shares Outstanding | $195.86M | $62.11M | $193.28M | $251.36M |
| P/E Ratio | -21.89 | 26.0 | 43.3 | 18.0 |
| EPS | -3.73 | 8.21 | 1.4 | 3.23 |
| Day Low | 80.035 | 239.56 | 59.33 | 54.26 |
| Day High | 82.32 | 247.98 | 60.83 | 56.47 |
| Year Low | 42.09 | 175.19 | 49.26 | 33.76 |
| Year High | 93.415 | 282.15 | 66.28 | 57.57 |
| Average Price 50 | 74.1225 | 244.618 | 57.278 | 53.5656 |
| Average Price 200 | 71.3832 | 226.21762 | 56.29015 | 45.7899 |
| Volume | 905.62K | 397.13K | 547.02K | 1.38M |
| Average Volume | - | - | - | - |